Nizar A Mukhtar1, Priya Kathpalia, Joan F Hilton, Gene Lau, Albert Yu, Kevin Grumbach, Tung T Nguyen, Daniel Chan, Mandana Khalili. 1. Departments of *Medicine ∥Family and Community Medicine §San Francisco Department of Public Health #Liver Center, University of California San Francisco †Department of Epidemiology and Biostatistics, University of California, San Francisco ‡Kaiser Permanente San Francisco Medical Center ¶North East Medical Services, San Francisco, CA.
Abstract
GOALS: To evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and management practices across diverse primary care settings. BACKGROUND: Factors influencing adherence to recommended HBV screening and management guidelines are poorly defined. MATERIALS AND METHODS: Providers across various health care settings in San Francisco were surveyed. Multivariate analyses were used to identify factors associated with recommended HBV screening, vaccination, and disease monitoring. RESULTS: Of 277 (41.3%) responding providers, 42% reported performing HBV screening in >50% of at-risk patients, and 49%, HBV vaccination in >50% of eligible patients. Most reported appropriate monitoring of a majority of HBV-infected patients with alanine aminotransferase (79%) and HBV viral load (67%) every 6 to 12 months, but performed any hepatocellular carcinoma screening in 49%. Provider factors significantly associated with HBV screening were speaking an Asian language [odds ratio (OR), 3.27], offering HBV treatment (OR, 3.00), having >25% of Asian patients in practice (OR, 2.10), practicing in safety net settings (OR, 7.51) and having higher barrier score (OR, 0.74). Appropriate HBV monitoring was associated with provider speaking an Asian language (OR, 3.43) and provider age (OR, 0.68/decade). Hepatocellular carcinoma screening was associated with having >25% of patients speaking English as a second language (OR, 4.26) and practicing in safety net settings (OR, 0.14). CONCLUSIONS: Rates of adherence to HBV guidelines were suboptimal irrespective of practice setting and were influenced by certain provider, patient and practice factors. This study reinforces the importance of engaging primary care providers in development, dissemination, and implementation of evidence-based HBV practice guidelines.
GOALS: To evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and management practices across diverse primary care settings. BACKGROUND: Factors influencing adherence to recommended HBV screening and management guidelines are poorly defined. MATERIALS AND METHODS: Providers across various health care settings in San Francisco were surveyed. Multivariate analyses were used to identify factors associated with recommended HBV screening, vaccination, and disease monitoring. RESULTS: Of 277 (41.3%) responding providers, 42% reported performing HBV screening in >50% of at-risk patients, and 49%, HBV vaccination in >50% of eligible patients. Most reported appropriate monitoring of a majority of HBV-infectedpatients with alanine aminotransferase (79%) and HBV viral load (67%) every 6 to 12 months, but performed any hepatocellular carcinoma screening in 49%. Provider factors significantly associated with HBV screening were speaking an Asian language [odds ratio (OR), 3.27], offering HBV treatment (OR, 3.00), having >25% of Asian patients in practice (OR, 2.10), practicing in safety net settings (OR, 7.51) and having higher barrier score (OR, 0.74). Appropriate HBV monitoring was associated with provider speaking an Asian language (OR, 3.43) and provider age (OR, 0.68/decade). Hepatocellular carcinoma screening was associated with having >25% of patients speaking English as a second language (OR, 4.26) and practicing in safety net settings (OR, 0.14). CONCLUSIONS: Rates of adherence to HBV guidelines were suboptimal irrespective of practice setting and were influenced by certain provider, patient and practice factors. This study reinforces the importance of engaging primary care providers in development, dissemination, and implementation of evidence-based HBV practice guidelines.
Authors: Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili Journal: Dig Dis Sci Date: 2013-09-20 Impact factor: 3.199
Authors: Christopher E McGowan; Teresa P Edwards; Mai-Uyen T Luong; Paul H Hayashi Journal: Clin Gastroenterol Hepatol Date: 2014-08-10 Impact factor: 11.382
Authors: Henry Pollack; Su Wang; Laura Wyatt; Chia-Hui Peng; Kejia Wan; Chau Trinh-Shevrin; Kay Chun; Thomas Tsang; Simona Kwon Journal: Health Aff (Millwood) Date: 2011-10 Impact factor: 6.301
Authors: G M McQuillan; P J Coleman; D Kruszon-Moran; L A Moyer; S B Lambert; H S Margolis Journal: Am J Public Health Date: 1999-01 Impact factor: 9.308
Authors: Kali Zhou; Jennifer L Dodge; Joshua Grab; Eduard Poltavskiy; Norah A Terrault Journal: Aliment Pharmacol Ther Date: 2020-05-20 Impact factor: 8.171
Authors: Mandana Khalili; Nicole J Kim; Janice Y Tsoh; Judith M E Walsh; L Elizabeth Goldman; Ginny Gildengorin; Ching Wong; Mi T Tran; Edgar Yu; Michael Thanh Sharp; Vivian H LeTran; Vi-Van Nguyen; Tung T Nguyen Journal: J Gen Intern Med Date: 2022-01-06 Impact factor: 6.473
Authors: Nizar A Mukhtar; Donna M Evon; Colina Yim; Anna S Lok; Nadra Lisha; Mauricio Lisker-Melman; Mohamed Hassan; Harry L A Janssen; Mandana Khalili Journal: Dig Dis Sci Date: 2020-04-01 Impact factor: 3.199